Medtronic ($MDT) scored a pivotal CE mark that will help expand the market for its CoreValve transcatheter aortic valve replacement (TAVR). This latest regulatory nod ...

MINNEAPOLIS - Medtronic, Inc. today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic ...

As clinicians have gained experience with transcatheter aortic valve implantation (TAVI) using the CoreValve system, the procedure has become safer—with fewer severe bleeds and cerebrovascular ...

Natural aortic valves are subject to a great deal of physical stress. After decades, they can become stenosed or incompetent, but the prostheses that replace them end up being subjected to the same ...

SILVER SPRING, MD — The US Food and Drug Administration (FDA) has expanded the indication for the CoreValve System (Medtronic, Minneapolis, MN) to include aortic "valve-in-valve" replacement ...

Patients with narrowed heart valves who are too sick to undergo traditional open heart surgery to replace those valves now have a nonsurgical option that can relieve their symptoms and possibly ...

Medtronic, Inc. 's ( MDT) CoreValve transcatheter aortic valve replacement (TAVR) system continues to provide efficient treatment at two years for extreme-risk patients, the company announced at the ...

Market-Leading Transcatheter Aortic Valve Delivers Positive Clinical Outcomes Through Two Years in Major International Study; Achieves 10,000-patient Milestone PARIS--(BUSINESS WIRE)-- New clinical ...

Siegburg, Germany - Percutaneous implantation of the self-expanding CoreValve aortic valve bioprosthesis in the first-ever series of patients shows that the procedure is feasible in those deemed too ...

The FDA has approved, for the first time, a transcathter heart valve for valve-in-valve (VIV) procedures in patients whose surgical aortic heart valves have failed. The agency expanded the approved ...